Sanne
Sanne Grinovero, London GB
Patent application number | Description | Published |
---|---|---|
20160057053 | Light-Weight Fork Channels for Clustering - A method for light-weight fork channels for clustering is disclosed. The method includes receiving, by a processing device, a message at a main channel used for group communication between processes executed by the processing device, identifying a fork channel identifier (ID) and a fork stack ID in a header of the message, processing the message with a fork stack corresponding to the fork stack ID in the header of the message, the fork stack comprising a subset of protocols of a main protocol stack of the main channel, and providing the message to a fork channel corresponding to the fork channel ID, wherein the fork channel to utilize the fork stack to separate messages for the fork channel from the main channel. | 02-25-2016 |
Sanne Schrøder Glad, Ballerup DK
Patent application number | Description | Published |
---|---|---|
20110230419 | IAP BINDING COMPOUNDS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the treatment of proliferative diseases, such as cancer, for promoting apoptosis in proliferating cells, and for sensitizing cells to inducers of apoptosis. The present invention furthermore provides a polymeric compound of formulas (VI) or (VII), comprising either at least two monomeric units of compounds of formula (I), or at least one monomeric unit of a compound of formula (I) and an entity E. The present invention further relates to pharmaceutical compositions comprising said compounds of formulas (I), (VI), and (VII) and the use of said compounds in medicine. | 09-22-2011 |
Sanne Weijzen, Bilthoven NL
Patent application number | Description | Published |
---|---|---|
20130072545 | MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT - The invention relates to the diagnostic and therapeutic uses of a miRNA molecule or an equivalent thereof wherein a source of said miRNA molecule or equivalent thereof comprises at least 80 nucleotides and comprises a motif having at least 98% identity with the motif represented by SEQ ID NO:1 or a source thereof in a disease and condition associated with EMT (Epithelial to Mesenchymal Transition). | 03-21-2013 |
20140005251 | MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis | 01-02-2014 |
Sanne Wijnans, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20120071693 | PROCESS FOR THE PRODUCTION OF ETHYLENE GLYCOL AND RELATED COMPOUNDS - The present invention provide a process for the production of compounds of general formula (I), Y—CH | 03-22-2012 |